Trial · NCT07895654
Strap To Reduce Apnea in Preterm Infants: A Randomized Crossover Trial
NCT07895654, Not applicable, Not yet recruiting, University of Alabama at Birmingham
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Strap To Reduce Apnea in Preterm Infants: A Randomized Crossover Trial. Trials, record NCT07895654. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07895654
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Strap To Reduce Apnea in Preterm Infants: A Randomized Crossover Trial
- NCT number
- NCT07895654
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 20 participants, estimated
- Lead sponsor
- University of Alabama at Birmingham
- Conditions
- Apnea of Prematurity, Intermittent Hypoxemia, Bronchopulmonary Dysplasia of Newborn
- Interventions
- Chinstrap
- First posted
- 2026-10-26
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | IH80 Duration Per Event (IH80dpe) | 24-hour study period (each crossover period) | Average duration per intermittent hypoxemia event with SpO₂ below 80% for at least 10 seconds (IH80dpe), measured in seconds per event per 24-hour study period. Calculated as total cumulative duration of SpO₂ below 80% events divided by the number of events in the 24-hour period. |
| Secondary | IH80 Frequency | 24-hour study period (each crossover period) | Number of intermittent hypoxemia events with SpO₂ below 80% for at least 10 seconds per 24-hour study period |
| Secondary | IH85 Frequency | 24-hour study period (each crossover period) | Number of intermittent hypoxemia events with SpO₂ below 85% for at least 10 seconds per 24-hour study period |
| Secondary | IH85 Duration Per Event (IH85dpe) | 24-hour study period (each crossover period) | Average duration per intermittent hypoxemia event with SpO₂ below 85% for at least 10 seconds, in seconds per event per 24-hour study period |
| Secondary | IH90 Frequency | 24-hour study period (each crossover period) | Number of intermittent hypoxemia events with SpO₂ below 90% for at least 10 seconds per 24-hour study period |
| Secondary | IH90 Duration Per Event (IH90dpe) | 24-hour study period (each crossover period) | Average duration per intermittent hypoxemia event with SpO₂ below 90% for at least 10 seconds, in seconds per event per 24-hour study period |
| Secondary | Time in Target SpO₂ Range | 24-hour study period (each crossover period) | Proportion of time with SpO₂ within the target range of 91-95% per 24-hour study period |
| Secondary | Bradycardia Frequency | 24-hour study period (each crossover period) | Number of bradycardia episodes (heart rate below 100 bpm for at least 10 seconds) per 24-hour study period |
| Secondary | Fraction of Inspired Oxygen (FiO₂) | 24-hour study period (each crossover period) | Median FiO₂ required to maintain SpO₂ within target range during the 24-hour study period |
| Secondary | Transcutaneous CO₂ (TcCO₂) | 24-hour study period (each crossover period) | Median transcutaneous CO₂ in mmHg during the 24-hour study period |
1 to 10 of 15Source ClinicalTrials.gov
See all 15 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers7
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07895654
GET https://conductscience.org/api/trials/v1/NCT07895654/registered